us fda issues observations on aurobindo pharma and ajanta pharma | business lunch | cnbc-tv18
Published 1 year ago • 805 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:31
u.s. fda issues 10 observations to aurobindo pharma under form 483 | halftime report | cnbc-tv18
-
17:15
aurobindo pharma: unit 4 | us fda blow; issues 9 observations to unit 4 | cnbc tv18
-
23:49
us fda issues 6 observation on sun pharma | halftime report | cnbc-tv18
-
3:24
aurobindo pharma under pressure after us fda issues 9 observations for eugia pharma's unit iii
-
1:54
aurobindo pharma's arm apl healthcare units get vai status from u.s. fda | halftime report
-
5:32
both high-end and low-end consumers pullback on restaurant spending, says mizuho's baumgartner
-
3:39
oil prices rise on middle east tensions
-
4:39
fed shifting to dual-mandate of the labor market and inflation, says allianz's mohamed el-erian
-
19:06
aurobindo pharma gains over 2% amid drug approval from usfda | business lunch | cnbc tv18
-
2:35
aurobindo pharma under pressure after us fda issues warning letter for eugia unit iii | cnbc tv18
-
8:09
aurobindo pharma's unit-iv plant gets clearance from us fda | midcap radar
-
1:15
aurobindo pharma gets 3 us fda approvals overnight
-
10:28
bino pathiparampil on indian pharma cos track record with the u.s fda | halftime report | cnbc-tv18
-
1:25
us fda surprise inspection underway at granules india’s hyderabad facility since yesterday: srcs
-
2:33
zydus life dips over 5% after teva gets us fda approval for asacol hd generic | cnbc tv18
-
2:14
prabhudas lilladher's on the future of reliance, aurobindo pharma | cnbc tv18
-
1:16
aurobindo pharma temporarily halts production at eugia’s unit-iii after 9 us fda observations
-
1:00
us fda on sun pharma’s dadra unit: failed to clean, maintain, sanitise equipment at apt intervals
-
2:46
global pharma recalls eye drops from us market after usfda, us cdc issue warning | cnbc-tv18
-
10:40
us business was impacted by seasonality in q1fy25: aurobindo pharma | cnbc tv18
-
3:03
sun pharma dadra unit: us fda warning letter shows multiple repeat observations | n18v | cnbc tv18
-
8:00
focussed on operating efficiency and leverage: awfis space solutions | cnbc tv18